Top section
Top section
Shipping company’s “amazingly well received” Greek offering draws €656m of demand
Africa’s largest IPO backed by Africa-focused Pan-African Refinery Investment after agreeing to $1bn underwriting programme
◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
More articles
More articles
More articles
-
Carnival Cruises has completed a partial buy-back of the $2bn three-year convertible bond it issued in April, to give it extra liquidity during the Covid-19 pandemic. -
Ke Holdings has kicked off bookbuilding for a $2bn US listing. But it has come as one of its largest shareholders, internet giant Tencent Holdings, was blindsided by the US with sanctions.
-
Aim-listed oil and gas producer i3 Energy has announced a £30m fundraising to finance its reverse takeover of Canadian firm Gain Energy’s petroleum and infrastructure assets.
-
This week in Keeping Tabs: confronting dollar bears, Lebanon’s crisis, the power of debt in Ireland, and funding equity research.
-
Freeline, the UK gene therapeutics company, has priced its IPO on the Nasdaq exchange at the top of the pricing range, with investors willing to pay a big premium for the stock. The company is the latest deal in a global biotech issuance spree that has passed $60bn.
-
Hong Kong-listed Shanghai Henlius Biotech has won approval from the Mainland securities regulator to sell a chunk of new shares.
Sub-sections
shared comment list
